Loading clinical trials...

Prospective Study on HIV-related Hodgkin Lymphoma | Clinical Trials | Clareo Health

UNKNOWNPhase 2NCT01468740

Prospective Study on HIV-related Hodgkin Lymphoma

Standard therapy for HIV-related Hodgkin lymphoma (HIV-HL) has not been defined. This trial was initiated to investigate a risk adapted treatment strategy in patients (pts) with HIV-HL as established ...

Lead sponsor: Harlachinger Krebshilfe e.V.•8 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Marcus Hentrich, MD

CONTACT

0049 89 6210 2663 marcus.hentrich@klinikum-muenchen.de

Related studies

COMPLETEDNA

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

NCT00112593 · Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, and more

WITHDRAWNNA

Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma

NCT01769911 · Adult Nasal Type Extranodal NK/T-cell Lymphoma, AIDS-related Diffuse Large Cell Lymphoma, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 9, 2011Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2

Enrollment130

Start dateMar 2004

Last updatedNov 9, 2011

Condition

HIV-associated Hodgkin Lymphoma

Locations shown

Vivantes Auguste Victoria Klinikum

Berlin

Ärzteforum Seestrasse

Berlin

Universiy of Bonn

Bonn

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 9, 2011Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions